Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/14/2000US6146645 Uses of oil bodies
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146631 Administering a fusion protein comprising a gelonin prefered amino acid sequeance, a targeting sequence that allows internalization of fusion protein in the cell, internizing the fusion protein in the cell, eliminating the cell
11/14/2000US6146630 Inhibitors for the adhesion of lymphocytes to glandular cells
11/14/2000US6146629 Hybridoma cell line producing human monoclonal antibodies capable of binding to the hepatitis b virus surface antigen
11/14/2000US6146627 Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody
11/14/2000US6146626 Mixtures of purified enzymes from clostridium histolyticum, comprising collagenase with hexapeptide as a substrate, collagenase using azocoll as substrate and elastase, used as wound healing agent
11/14/2000US6146625 Deactivating pathological amounts of platelet-activating factor in mammal by administering a culture product protein
11/14/2000US6146624 Human ubiquitin-conjugating enzymes
11/14/2000CA2179207C Parathyroid hormone formulation
11/14/2000CA2074839C Modified factor vii anticoagulant proteins
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000067033A1 Methods of diagnosing or treating alzheimer's disease
11/09/2000WO2000067029A1 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12
11/09/2000WO2000067024A1 Cancer treatment with endothelin receptor antagonists
11/09/2000WO2000067016A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066782A2 Diagnostic assay for diabetes mellitus based on mutational burden
11/09/2000WO2000066778A1 Pituitrone gene and polypeptides
11/09/2000WO2000066754A1 Protein c derivatives
11/09/2000WO2000066753A2 Modified vitamin k-dependent polypeptides
11/09/2000WO2000066752A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide
11/09/2000WO2000066741A2 Conserved neisserial antigens
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066734A1 Methods of treating hypertension
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066729A1 Meg-3 protein
11/09/2000WO2000066728A1 StAR HOMOLOGUES
11/09/2000WO2000066725A1 Use of inducible no-synthase antisense oligonucleotides for preventing and treating cerebral ischemia
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066721A2 Decreasing adipose mass by altering rsk2 activity
11/09/2000WO2000066720A2 The use of adeno-associated virus (aav) deliver cytoprotective genes
11/09/2000WO2000066717A1 Human brain carboxypeptidase b
11/09/2000WO2000066709A2 Zymogen activation system
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066707A2 Novel thiamine transporter, a polynucleotide encoding same and their uses
11/09/2000WO2000066632A1 Agonists or antagonists for haemopoietic growth factors
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066629A1 Modified exendins and exendin agonists
11/09/2000WO2000066628A1 Neurite outgrowth and guidance by tenascin-c
11/09/2000WO2000066627A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000WO2000066626A1 Novel peptide y-2
11/09/2000WO2000066624A1 Helicobacter pylori antigens
11/09/2000WO2000066622A1 T20/dp178 and t21/dp107 are activators of human phagocyte formyl peptide receptors
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066620A2 Morphogen-induced enhancement of fertility
11/09/2000WO2000066619A2 Means and methods for altering the functional properties in eukaryotic cells
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066617A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000WO2000066616A1 METHODS AND COMPOSITIONS FOR CONTROLLING DENTAL CARIES, AND RECOMBINANT SmaA POLYPEPTIDES USEFUL FOR SAME
11/09/2000WO2000066608A1 Tumor necrosis factor-gamma
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066550A1 New compounds
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066177A1 GENE THERAPY USING TGF-$g(b)
11/09/2000WO2000066176A2 Agent for gene therapy and for the prevention of metastases, as well as for the gene therapy of tumors
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000066162A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066155A1 Methods for preventing reactivation of latent virus and controlling virus replication
11/09/2000WO2000066153A1 RAS ONCOGEN p21 PEPTIDE VACCINES
11/09/2000WO2000066151A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000WO2000066150A1 New use of a substance in pns
11/09/2000WO2000066149A1 Medicines useful for treating disorders of regulation of body fatness and diseases related to disorders of leptin production
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066147A1 A method of inducing formation of kidney epithelia from mesenchymal precursors
11/09/2000WO2000066146A1 Structure-based design of compounds that inhibit detrimental cytotoxic t lymphocyte responses
11/09/2000WO2000066144A2 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections
11/09/2000WO2000066142A2 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
11/09/2000WO2000066141A2 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000WO2000066140A1 A pharmaceutical composition of concentrates for microemulsion and self-emulsifying drug delivery system
11/09/2000WO2000066139A2 Biochemical methods that eliminate corneal scars, opacification and haze
11/09/2000WO2000066138A2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066116A2 Stable solid pharmaceutical compositions containing enalapril maleate
11/09/2000WO2000066090A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000041713A3 Composition and method for improving function of embryonic kidney transplants
11/09/2000WO2000041463A3 Combination of hepatitis b vaccine with antiviral agents
11/09/2000WO2000040705A3 Human desaturase gene and uses thereof
11/09/2000WO2000039293A3 Agent for inhibiting the regeneration of tissue
11/09/2000WO2000039277A3 Ndsp nucleic acids and polypeptides
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000037105A3 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/09/2000WO2000035472A3 Cytokine combination therapy
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
1 ... 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 ... 3163